Loading clinical trials...

BIO-K+ CL1285 for Prevention of Recurrent Clostridium Difficile Infection | Clinical Trials | Clareo Health

SUSPENDEDPhase 3NCT01202630

BIO-K+ CL1285 for Prevention of Recurrent Clostridium Difficile Infection

The primary objective of this study is to evaluate the efficacy of BIO-K+ CL1285 for prevention of recurrent Clostridium difficile infection.

Lead sponsor: Bio-K Plus International Inc.•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

RECRUITINGPhase 3

VE303 for Prevention of Recurrent Clostridioides Difficile Infection

NCT06237452 · Clostridium Difficile, Clostridium Difficile Infections, and more

COMPLETEDNA

Dietary Optimization of Microbiome Recovery Following Fecal Microbiota Transplantation

NCT05826418 · Recurrent Clostridium Difficile Infection, Fecal Microbiota Transplant

UNKNOWNPhase 3

Fecal Filtrate as a Treatment Option of Multiple Recurrent Clostridioides Difficile Infection

NCT04960306 · Clostridium Difficile Infection, Recurrent Clostridium Difficile Infection

COMPLETEDPhase 2

Microbiota Restoration Therapy for Recurrent Clostridium Difficile-associated Diarrhea

NCT01925417 · Recurrent Clostridium Difficile Infection

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 15, 2016Terms

Trial snapshot

StatusSUSPENDED

PhasePHASE3

Enrollment140

Start dateJun 2010

Last updatedJan 15, 2016

Condition

Recurrent Clostridium Difficile Infection

Locations shown

Parker Jewish Institute

New Hyde Park, New York

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 15, 2016Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions